0001637514-18-000006.txt : 20180315 0001637514-18-000006.hdr.sgml : 20180315 20180315163557 ACCESSION NUMBER: 0001637514-18-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180315 DATE AS OF CHANGE: 20180315 EFFECTIVENESS DATE: 20180315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoBioscience, Inc. CENTRAL INDEX KEY: 0001637514 IRS NUMBER: 472789100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307871 FILM NUMBER: 18692940 BUSINESS ADDRESS: STREET 1: 3463 MAGIC DRIVE, SUITE 120 CITY: SAN ANTONIO STATE: TX ZIP: 78229 BUSINESS PHONE: 210-767-2727 MAIL ADDRESS: STREET 1: 3463 MAGIC DRIVE, SUITE 120 CITY: SAN ANTONIO STATE: TX ZIP: 78229 FORMER COMPANY: FORMER CONFORMED NAME: CytBioscience, Inc. DATE OF NAME CHANGE: 20180122 FORMER COMPANY: FORMER CONFORMED NAME: Cytocentrics, Inc. DATE OF NAME CHANGE: 20150323 D 1 primary_doc.xml X0708 D LIVE 0001637514 CytoBioscience, Inc. 3463 MAGIC DRIVE, SUITE 120 SAN ANTONIO TX TEXAS 78229 210-767-2727 DELAWARE CytBioscience, Inc. Cytocentrics, Inc. Corporation true 2014 James R. Garvin 3463 Magic Drive Suite 120 San Antonio TX TEXAS 78229 Executive Officer Director Alan Dean 3463 Magic Drive Suite 120 San Antonio TX TEXAS 78229 Director Paul Castella 3463 Magic Drive Suite 120 San Antonio TX TEXAS 78229 Director Ian Clements 3463 Magic Drive Suite 120 San Antonio TX TEXAS 78229 Director Biotechnology Decline to Disclose 06b false 2018-03-14 false true true Intended merger 0 Danielle Hughes 2189447 Divine Capital Markets 118212 39 Broadway 36th Floor New York NY NEW YORK 10006 CA CALIFORNIA FL FLORIDA IL ILLINOIS MD MARYLAND MI MICHIGAN MN MINNESOTA NY NEW YORK WA WASHINGTON false 1530000 1530000 0 false 3 90000 0 250000 true false CytoBioscience, Inc. James R. Garvin James R. Garvin CEO 2018-03-15